MedPath

Center for Research in Security Prices, LLC

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Phase 3
Terminated
Conditions
Elevated Prostate Specific Antigen
Interventions
First Posted Date
2009-02-10
Last Posted Date
2014-08-01
Lead Sponsor
University of Chicago
Target Recruit Count
85
Registration Number
NCT00840294
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

Phase 2
Completed
Conditions
Pre-diabetes
Interventions
First Posted Date
2009-01-28
Last Posted Date
2017-02-10
Lead Sponsor
University of Chicago
Target Recruit Count
53
Registration Number
NCT00831129
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Vitamin D Levels in Children Undergoing Adenotonsillectomies and Controls

Completed
Conditions
Tonsillitis
First Posted Date
2009-01-27
Last Posted Date
2023-05-06
Lead Sponsor
University of Chicago
Target Recruit Count
60
Registration Number
NCT00829972
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries

Phase 2
Completed
Conditions
Hypertension
Diabetes
Interventions
First Posted Date
2009-01-27
Last Posted Date
2016-02-05
Lead Sponsor
University of Chicago
Target Recruit Count
70
Registration Number
NCT00829296
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago, Chicago, Illinois, United States

Tumor Gene Expression in Women With Ovarian Cancer

Phase 4
Completed
Conditions
Ovarian Cancer
Interventions
Drug: Placebo
Drug: Dexamethasone
First Posted Date
2009-01-06
Last Posted Date
2016-07-13
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00817479
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Sleep Disturbances as a Non-Traditional Risk Factor in Chronic Kidney Disease- University of Illinois

Completed
Conditions
Chronic Kidney Disease
First Posted Date
2009-01-06
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
89
Registration Number
NCT00817492
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Illinois at Chicago, Chicago, Illinois, United States

Sleep Disturbances as a Risk Factor in Chronic Kidney Disease

Not Applicable
Completed
Conditions
Chronic Kidney Disease
Interventions
Other: Controls Short sleep
Other: CKD- sleep extension
First Posted Date
2009-01-06
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
40
Registration Number
NCT00817427
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy

Completed
Conditions
Chronic Kidney Disease
Sleep Loss
First Posted Date
2009-01-06
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
353
Registration Number
NCT00817674
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

Impact of a Sleep Debt in Middle-Aged and Older Adults

Not Applicable
Completed
Conditions
Sleep Restriction
Interventions
Other: Sleep restriction
First Posted Date
2009-01-06
Last Posted Date
2017-01-11
Lead Sponsor
University of Chicago
Target Recruit Count
72
Registration Number
NCT00817700
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Chicago, Chicago, Illinois, United States

A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

Phase 2
Withdrawn
Conditions
Hepatitis C
Hepatitis C Virus
Interventions
Drug: Fluvastatin
Drug: Peginterferon alfa2a
Drug: ribavirin
First Posted Date
2008-12-25
Last Posted Date
2013-07-01
Lead Sponsor
University of Chicago
Registration Number
NCT00814606
ยฉ Copyright 2025. All Rights Reserved by MedPath